Ambea AB (CHIX:AMBEAS) Marketable Securities: kr0 Mil (As of Mar. 2026)


CHIX:AMBEAS Ambea AB CHIX:AMBEAS
83 GF Score
Price kr144.20
GF Value kr110.48
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Ambea AB Marketable Securities?

Ambea AB CHIX:AMBEAS 83 Marketable Securities is kr0 Mil as of Mar. 2026. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 83/100 and a GF Value™ of kr110.48 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Ambea AB's Marketable Securities for the quarter that ended in Mar. 2026 was kr0 Mil.

Ambea AB  (CHIX:AMBEAs) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Ambea AB Marketable Securities Related Terms

Ambea AB Marketable Securities Historical Data

* Premium members only.

The historical data trend for Ambea AB's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ambea AB Marketable Securities Chart

Ambea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ambea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
CHIX:AMBEAS
83GF Score
Ambea AB CHIX:AMBEAS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ambea AB Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of kr0 Mil mean?
Ambea AB (CHIX:AMBEAS) has a Marketable Securities of kr0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ambea AB and its competitors.
Is Ambea AB's Marketable Securities too high?
Ambea AB's current Marketable Securities is kr0 Mil. Overall, Ambea AB has a GF Score™ of 83/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's Marketable Securities compare to HCA and THC?
Ambea AB's Marketable Securities of kr0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Ambea AB and its competitors. Ambea AB's current Marketable Securities is kr0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Based on GuruFocus' analysis, Ambea AB (CHIX:AMBEAS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr110.48, compared to a current price of kr144.20 — trading 30.5% above its estimated fair value. The current Marketable Securities is kr0 Mil. Ambea AB's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current Marketable Securities is kr0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?

Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued. The current stock price of kr144.20 is trading 30.5% above its estimated GF Value™ of kr110.48. GuruFocus considers Ambea AB to be Significantly Overvalued.

Key valuation signals for CHIX:AMBEAS:

  • Marketable Securities: kr0 Mil
  • GF Value™: kr110.48 vs. price of kr144.20 (30.5% above fair value)
  • GF Score™: 83/100 with 8 warning signs

No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ambea AB Business Description

Address Rontgenvagen 3D, Box 1565, Solna, Stockholm, SWE, 171 29
Ambea AB is a Swedish care-provider group focused on elderly care, disability care, psychosocial support, housing, staffing, and training across the Nordic region. The company's segment includes: i) Nytida: Comprises social care services for children, youth and adults, in Sweden, ii) Vardaga: Comprises nursing homes and home care in Sweden, iii) Stendi: Comprises social care for children, youth and adult in Norway, iv) Validia: Comprises social care for children, v) Altiden: Comprises social care for children, youth and adults as well as elderly care in Denmark, and vi) Klara: Comprises competence and staffing solutions for elderly and social care, and student health services in Sweden. The majority of the company's revenue is derived from the Vardaga segment.
83GF Score

Get the complete analysis for CHIX:AMBEAS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr144.20
Price
kr110.48
GF Value